Provider review
LillyDirect review
Brand-name Zepbound priced by dose, so the starting dose is the cheapest fill.
The manufacturer's own pharmacy sets a self-pay price per strength; it fills prescriptions but does not write them.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Zepbound $299/mo at 2.5 mg, rising with the dose
Visit LillyDirectPrice as published
LillyDirect
Zepbound $299/mo at 2.5 mg, rising with the dose
- Vs median
- $130/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Quotes off the lowest dose
- Dispensed
- Not a compounded product
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
LillyDirect is Eli Lilly's own pharmacy, and it is the clearest example anywhere of a price that follows the dose. Self-pay Zepbound, as a pen or a vial, costs least at the 2.5 mg starting dose, more at 5 mg and more again at the maintenance doses, with the higher price applying if you miss a refill window. The Foundayo pill works the same way. For someone deliberately staying low, that is the structure you want: taking less really does cost less, and the drug is the FDA-approved product, not a compounded copy. Two cautions. Lilly says 2.5 mg is a starting dose and is not approved as a maintenance dose, so staying there long term is your prescriber's off-label call. And a month here is 28 days, so a year means 13 fills, and needles or syringes are a separate purchase. LillyDirect does not prescribe. You need your own clinician, or one of the independent telehealth services it lists, to send the prescription, and that visit is paid separately. With commercial insurance the copay can be very low.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want brand-name tirzepatide and a price that drops with a lower dose
- You already have a clinician who will prescribe
- You want to buy straight from the manufacturer
Look elsewhere if
- You want a prescriber included in the price
- You want a low dose that is approved for long-term use as labeled
- You budget by the calendar month: each fill is 28 days
What it actually costs
Price as published
Zepbound $299/mo at 2.5 mg, rising with the dose
- Vs median
- $130/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
39 of the 407 programs here price a small dose this way. The manufacturer prices brand-name tirzepatide by strength, so the starting dose is the cheapest fill and every step up costs more. It is the plainest case of a price that follows the dose, with two limits: a month is twenty-eight days, and the starting dose is not approved for maintenance.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
What it does well
- The price is set by dose, so taking a smaller dose actually costs less
- Brand-name, FDA-approved tirzepatide from the manufacturer's own pharmacy, so the compounding question does not arise
- Every self-pay price is printed by strength before anything is required of you
- Insurance and self-pay are both handled, and with coverage the copay can be very low
- Medicare patients who qualify can use its GLP-1 Bridge program
Pharmacy, labs and oversight
LillyDirect does not sell a compounded product, so no compounding pharmacy is involved. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
3 of 4 published openly
What LillyDirect publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNot a compounded product, so no compounding pharmacy is involved.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
LillyDirect is Eli Lilly's direct-to-patient pharmacy service for its own medicines, including Zepbound, Mounjaro and the Foundayo pill. It is not a telehealth company: your own doctor, or an independent telehealth provider from the list it links to, sends a prescription to LillyDirect Pharmacy, and LillyDirect then handles savings, prior authorization and delivery, with retail pickup for some products. The single-dose vials are sold only here and only for self-pay. Because the price is set per strength, the low doses this site is about really are cheaper: 2.5 mg costs less than 5 mg, which costs less than the maintenance doses. Lilly states that 2.5 mg is a starting dose and is not approved for maintenance, so staying on it is an off-label decision for your prescriber. Nothing is compounded.
The honest cons
A month is 28 days, so a year holds 13 fills rather than 12
- LillyDirect does not prescribe: you need your own clinician or a separately paid telehealth visit
- Lilly says 2.5 mg is a starting dose and not approved for maintenance, so holding it long term is off-label
- The maintenance-dose price depends on refilling within 45 days, and it jumps if you miss that window
- Pen needles or syringes are an extra purchase
- Intentional microdosing of a GLP-1 is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
LillyDirect is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs to compare with LillyDirect. Both are partners: we may earn a commission if you start care through these links.
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Where this sits
#406 of 407
Ordered with the companies that pay us first, and LillyDirect is not one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Microdosing Zepbound
- Microdosing tirzepatide
- Low dose vs full dose
- The true annual cost of a plan
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Another program to compare
HumeCare+
$199–$299/mo (gated)
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HumeCare+ review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.